Department of Gynecologic Oncology, City of Hope, Duarte, California 91010, USA.
J Natl Compr Canc Netw. 2011 Jan;9(1):126-32. doi: 10.6004/jnccn.2011.0011.
Epithelial ovarian cancer is often diagnosed in advanced stages and typically managed with surgical debulking followed by chemotherapy. For patients with presumed early-stage ovarian cancer, comprehensive surgical staging is essential for management, because 31% are upstaged. Over the past 15 years, minimally invasive techniques have improved and are increasingly being used to treat patients with ovarian cancer. Currently, only retrospective data support laparoscopic staging of patients with a suspicious adnexal mass or those surgically diagnosed with presumed early-stage ovarian cancer. Laparoscopy is also used in patients undergoing second-look procedures and to help evaluate whether patients should undergo optimal tumor debulking procedures or be initially managed with neoadjuvant chemotherapy. Randomized clinical studies are needed to further support the role of minimally invasive surgery in the treatment of ovarian cancer.
上皮性卵巢癌通常在晚期诊断，通常采用手术减瘤术联合化疗治疗。对于疑似早期卵巢癌患者，全面的手术分期对于治疗至关重要，因为其中 31%的患者会出现分期升级。在过去的 15 年中，微创技术不断改进，并越来越多地用于治疗卵巢癌患者。目前，仅有回顾性数据支持对可疑附件包块或经手术诊断为疑似早期卵巢癌患者进行腹腔镜分期。腹腔镜还用于接受二次探查手术的患者，以及帮助评估患者是否应进行最佳肿瘤减瘤术，还是应最初接受新辅助化疗。需要开展随机临床试验以进一步支持微创外科在卵巢癌治疗中的作用。
